|
Direct-To-Consumer
Promotion: Public Meeting
September 22 and 23, 2003
Presentations
September 22, 2003
The Impact of Direct-to-Consumer
Prescription Drug Advertising on the Physician-Patient Relationship,
Kathryn Aikin, PhD., FDA.
National Surveys
DTC
and the AA Physician and Patient, Sharon Allison-Ottey, MD,
Coshar Medical.
Effectiveness
of and Attitudes Toward Medication Advertising, Linda Golodner,
National Consumers League.
The
DTC Information Process, Carol Rothkopt, Time Inc.
Consumer
Reaction to DTC Advertising of Prescription Medicines 1997-2002: A
Six-Year Tracking Study From Prevention and Men’s Health Magazines,
Edwin Slaughter, Rodale, Inc.
Consumer
and Physician Reports on the Health Effects of DTCA, Joel. S.
Weissman, PhD, Massachusetts General Hospital Institute for Health.
Effects on DTC on Prescribing
Effects
of DTC Advertising of Prescription Drugs on the Treatment of
Depression, Julie M. Donohue, Harvard Medical School.
Pharmaceutical Promotion: Perhaps
Don't Throw the Baby Out with the Bathwater, Robert Dubois, MD, PhD,
Zynx Health Inc.
How does
direct-to-consumer advertising (DTCA) affect prescribing? A survey
in primary care environments with and without legal DTCA, Barbara Mintzes, University of
British Columbia.
Assessment of Impact of DTC
Advertising on Prescription Drugs on Consumer and Prescribers, Petra T.
Schultz, PharmD, Mayo Clinic.
Advertising Effectiveness
The
Role of Drug Marketers in Providing Consumer Tools and Information
Needed to Enhance Public Health: Initial
Findings from the Consumer Experience Scorecard Project,
Lynn Benzing, Patient Marketing Group.
Cognitive Accessibility of
Prescription Drug Information, Ruth Day, Duke University.
DTC Advertising and its Impact of
Patient Healthcare Behaviors, Angela V. Hausman, PhD, University of
Texas.
Does DTC Promote Shared Decision
Making? A Preliminary Study, Henry N. Young, PhD., University of
California.
September 23, 2003
Utilization and Demand
DTC Effect on
Statins, John E.
Calfee, American Enterprise Institute.
"I saw this ad last
night...", Jon Hallberg, MD, University of Minnesota.
DTC Advertising and Pubic
Health,
Frank R. Lichtenberg, Columbia University.
Economic Impact of DTC
Advertising,
Neal Masia, Pfizer Inc.
Brief Summary
Alternatives to the "Brief
Summary," Michael Roberts, RPh, MBA, Catalina Health Resource.
Comparative Advertising, fair balance
and patient-consumer, Andrew Schirmer, McCann Erickson.
Effect of a prescription drug benefit
box on the public's assessment of drug efficacy, Lisa Schwartz, MD,
MS, VA Medical Center.
The public's valuation and
comprehension of a proposed prescription drug benefit box, Steven
Woloshin, MD, MS, VA Medical Center.
Patient/Physician Interaction -
Global
Physician-patient relationship:
Patient empowerment and the role of information, Mike Magee, Pfizer,
Inc.
The Views of Healthcare
Professionals and Consumers on Direct-To-Consumer Promotion of
Prescription Drugs in New Zealand, Dean G. Smith, PhD,
University of Michigan - Ann Arbor.
DTC
Advertising and Doctor-Patient Interactions,
Clifford Thumma, Pfizer, Inc.
Internet and Compliance
The internet and useful patient
information, Alan Goldhammer, PhD, Pharmaceutical Research and
Manufacturers of America.
Compliance, caregivers, and the
consumer, Gay Kassan, Parade Magazine
DTC advertising of prescription
medications on the WWW: Assessing the communication of risks and
benefits, William J. Vigilante, Jr., PhD, Robson Lapina. (Dr.
Vigilante was unable to attend due to illness but we are
posting the presentation he had submitted)
 Back
to Top 
Back to DTC Meeting Info
Date created: October 2, 2003 |
